» Articles » PMID: 31218231

Retrospective Analysis of Bone Metabolism in Patients on Waiting List for Simultaneous Pancreas-Kidney Transplantation

Overview
Journal J Diabetes Res
Publisher Wiley
Specialty Endocrinology
Date 2019 Jun 21
PMID 31218231
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Posttransplant osteoporosis, which evolves from preexisting bone pathologies, represents a serious complication with deteriorating consequences. The aim of our study was to evaluate epidemiological data on bone mineral density (BMD) in subjects with type 1 diabetes (T1DM) in advanced stages of diabetic nephropathy indicated for simultaneous pancreas-kidney transplantation (SPK). We retrospectively compiled biochemical and densitometrical data from 177 patients with T1DM at CKD (chronic kidney disease) stages G4-G5 (115 men, 62 women, median age 40 yr, diabetes duration 23 yr) enrolled on waiting list for SPK for the first time between the years 2011 and 2016. Median -scores were as follows: lumbar spine (LS): -0.8 [interquartile range -1.75 to 0.1]; total hip (TH): -1.2 [-1.75 to -0.6]; femoral neck (FN): -1.2 [-1.9 to -0.7]; and distal radius (DR): -0.8 [-1.4 to -0.1]. We noted a gender difference in LS, with worse results for men (-1.1 vs. -0.3) even after adjusting for BMI (body mass index) and glomerular filtration ( < 0.001). Osteoporotic and osteopenic ranges (based on -scores) for all major sites were 27.7% and 56.5%, respectively, with similar results across both genders. Women had a significantly higher proportion of normal BMD in LS than men (67.7 vs. 49.4%, < 0.05). Patients with T1DM at CKD stages G4-G5 exhibited serious BMD impairment despite their young age. Men surprisingly displayed lower -scores and higher percentages of pathological BMD values in LS than women did. The introduction of adequate preventive measures during the advanced stages of diabetic nephropathy to prevent bone loss is recommended.

Citing Articles

Increase in lumbar spine but not distal radius bone mineral density in adults after pancreas kidney transplantation.

Kratochvilova S, Maratova K, Sumnik Z, Brunova J, Hlavka Z, Girman P Bone Rep. 2024; 21:101764.

PMID: 38681747 PMC: 11046242. DOI: 10.1016/j.bonr.2024.101764.

References
1.
Ramsey-Goldman R, Dunn J, Dunlop D, Stuart F, Abecassis M, Kaufman D . Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res. 1999; 14(3):456-63. DOI: 10.1359/jbmr.1999.14.3.456. View

2.
Smets Y, Westendorp R, van der Pijl J, de Charro F, Ringers J, de Fijter J . Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet. 1999; 353(9168):1915-9. DOI: 10.1016/S0140-6736(98)07513-8. View

3.
Robertson R, Sutherland D, Lanz K . Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation. Diabetes. 1999; 48(9):1737-40. DOI: 10.2337/diabetes.48.9.1737. View

4.
Becker B, Brazy P, Becker Y, Odorico J, Pintar T, Collins B . Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int. 2000; 57(5):2129-35. DOI: 10.1046/j.1523-1755.2000.00064.x. View

5.
Pearce I, Ilango B, Sells R, Wong D . Stabilisation of diabetic retinopathy following simultaneous pancreas and kidney transplant. Br J Ophthalmol. 2000; 84(7):736-40. PMC: 1723560. DOI: 10.1136/bjo.84.7.736. View